ALX-1393;O-[2-BENZYLOXYPHENYL-3-FLUOROPHENYL]METHYL-L-SERINE;O-[(2-Benzyloxyphenyl-3-flurophenyl)methyl]-L-serine;L-Serine, O-[(3-fluorophenyl)[2-(phenylmethoxy)phenyl]methyl]-;ALX1393,ALX 1393;ALX-1393, 10 mM in DMSO
ALX-1393 is a selective GlyT2 inhibitor with antinociceptive effects against thermal, mechanical, and chemical stimuli in rat models of acute pain; it suppresses the late-phase response in the formalin test without affecting motor performance and inhibits mechanical and cold hyperalgesia in a dose-dependent manner.